Skip to content

Drug interactions

Fingolimod + Muromonab cd3

Severity: Major

Fingolimod and Muromonab cd3: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Muromonab-CD3 is a potent T-cell-depleting antibody, and fingolimod also lowers circulating lymphocyte counts. Their combination can produce profound immunosuppression with a high risk of serious and opportunistic infection.

What this interaction means in plain words

Fingolimod and Muromonab cd3 can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Evidence level: Low

Why it happens

Additive pharmacodynamic immunosuppression through T-cell depletion and lymphocyte sequestration.

What to do

Avoid the combination where possible. If both are required, monitor lymphocyte counts and closely observe for opportunistic infections.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Fingolimod and Muromonab cd3, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Fingolimod with Muromonab cd3?

MediHelp rates the interaction as major. Fingolimod and Muromonab cd3 can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Muromonab-CD3 is a potent T-cell-depleting antibody, and fingolimod also lowers circulating lymphocyte counts. Their combination can produce profound immunosuppression with a high risk of serious and opportunistic infection.

How serious is the interaction between Fingolimod and Muromonab cd3?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination where possible. If both are required, monitor lymphocyte counts and closely observe for opportunistic infections.

What other medicines interact with Fingolimod?

MediHelp also lists interactions of Fingolimod with, for example, Adenovirus types 4 and 7 live, Bcg vaccine live, Pimozide. The full list is on the Fingolimod page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in